BSEOmkar Pharmachem LtdMinimalNeutral
Announced Mon, 29 Dec · 12:46 IST

Dear Sir, Pursuant to SEBI (Prohibition of Insider Trading Regulations), 2015 as amended and in compliance with the terms of code of conduct of the company, please note that Trading ....

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Omkar Pharmachem Ltd has informed the BSE that its trading window will remain closed for designated persons and their immediate relatives from Thursday, January 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter and nine months ended December 31, 2025. The exact date of the results announcement will be communicated separately. This is a standard compliance filing under SEBI's Insider Trading Regulations to prevent insider dealing ahead of the earnings release.

Likely market impact

This is a routine regulatory filing with no direct impact on shareholders or stock price. It signals that the company's Q3 FY26 earnings results are expected soon, which investors should watch for as it could influence short-term price movement.